Mimedx (MDXG) EBIT Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -294.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -294.51% |
| Dec 31, 2025 | 90.67% |
| Sep 30, 2025 | 98.80% |
| Jun 30, 2025 | -47.25% |
| Mar 31, 2025 | -37.48% |
| Dec 31, 2024 | -28.64% |
| Sep 30, 2024 | 0.34% |
| Jun 30, 2024 | 116.35% |
| Mar 31, 2024 | 3,981.76% |
| Dec 31, 2023 | 36.95% |
| Sep 30, 2023 | 256.61% |
| Jun 30, 2023 | 212.48% |
| Mar 31, 2023 | 96.34% |
| Dec 31, 2022 | 780.23% |
| Sep 30, 2022 | -560.74% |
| Jun 30, 2022 | -2,250.24% |
| Mar 31, 2022 | -35.73% |
| Dec 31, 2021 | 107.99% |
| Sep 30, 2021 | 88.93% |
| Jun 30, 2021 | 93.00% |
| Mar 31, 2021 | 50.15% |
| Dec 31, 2020 | -230.28% |
| Sep 30, 2020 | -168.37% |
| Jun 30, 2020 | 65.70% |
| Mar 31, 2020 | -2.47% |
| Dec 31, 2019 | 45.52% |
| Sep 30, 2019 | 3,706.43% |
| Jun 30, 2019 | -1,119.28% |
| Mar 31, 2019 | -551.46% |
| Dec 31, 2018 | -137.29% |
| Sep 30, 2018 | -95.78% |
| Jun 30, 2018 | -76.78% |
| Mar 31, 2018 | -51.96% |
| Dec 31, 2017 | 371.07% |
| Sep 30, 2017 | 88.01% |
| Jun 30, 2017 | 102.56% |
| Mar 31, 2017 | 321.61% |
| Dec 31, 2016 | -214.14% |
| Sep 30, 2016 | -29.95% |
| Jun 30, 2016 | -37.00% |
| Mar 31, 2016 | -65.46% |
| Dec 31, 2015 | 66.62% |
| Sep 30, 2015 | 79.95% |
| Jun 30, 2015 | 1,541.84% |
| Mar 31, 2015 | 576.66% |
| Dec 31, 2014 | 429.46% |
| Sep 30, 2014 | 1,558.04% |
| Jun 30, 2014 | 47.33% |
| Mar 31, 2014 | -292.70% |
| Dec 31, 2013 | -45.21% |
| Sep 30, 2013 | 92.96% |
| Jun 30, 2013 | -533.29% |
| Mar 31, 2013 | 64.06% |
| Dec 31, 2012 | 60.08% |
| Sep 30, 2012 | -119.97% |
| Jun 30, 2012 | 95.14% |
| Mar 31, 2012 | 80.61% |